- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo semaglutide pen injector
Total 2155 results
-
Novo Nordisk A/SCompletedNon-alcoholic Fatty Liver Disease | Hepatobiliary DisordersGermany
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompleted
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)Recruiting
-
Zuyderland Medisch CentrumNederlandse Obestias Kliniek (NOK)Not yet recruitingObesity | Obesity, Morbid | Weight Gain
-
Shanghai Yinnuo Pharmaceutical Technology Co.,...The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...CompletedDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedOverweight and ObesityKorea, Republic of, Japan
-
Leonardo ClavijoAmgenUnknownPeripheral Arterial DiseaseUnited States
-
MedImmune LLCCompletedType 2 Diabetes MellitusUnited States
-
Radboud University Medical CenterCompleted
-
Novo Nordisk A/SCompletedObesity | Diabetes | Metabolism and Nutrition DisorderUnited Kingdom
-
Ministry of Health, Saudi ArabiaNot yet recruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Japan, Puerto Rico, Canada, France, Mexico, Poland, Russian Federation, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Japan, Puerto Rico, Serbia, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria
-
Shanghai Yinnuo Pharmaceutical Technology Co.,...Shanghai 6th People's HospitalCompleted
-
University Hospital, LilleNational Research Agency, FranceCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, Poland, Russian Federation, Spain, Canada, Denmark, Taiwan, Malaysia, United Kingdom, Turkey, Germany, Bulgaria, Argentina, Australia, Thailand, Algeria, Brazil
-
Shanghai Yinnuo Pharmaceutical Technology Co.,...Active, not recruiting
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingType 2 Diabetes MellitusChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, United Kingdom, Canada, Spain, Denmark, Austria, Serbia, South Africa, Sweden, Italy, Bulgaria, Germany, Malaysia
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
ShireTakeda Development Center Americas, Inc.Completed
-
Seoul National University HospitalSeoul National UniversityCompletedDiabetes MellitusKorea, Republic of
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Col... and more
-
University of California, San DiegoRecruitingType 2 Diabetes Mellitus in Obese | Fibrosis, Liver | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, United Kingdom, Canada, Sweden, Ireland, Argentina, Brazil, Lebanon, Malaysia, Mexico, Italy
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Chronic Kidney DiseaseSpain, United States, Italy, Denmark, Poland, South Africa, Canada, France
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer´s DiseaseCanada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Denmark, Sweden, Austria
-
Novo Nordisk A/SCompletedObesityUnited States, Spain, Australia, Hungary, United Kingdom, Netherlands, Canada, Argentina, Czechia, Germany, Denmark, Israel, Poland
-
Loma Linda UniversityNovo Nordisk A/SRecruitingObesity | Weight Loss | Overweight or Obesity | Weight, Body | Obesity; Drug | Weight Loss TrajectoryUnited States
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited States, Spain, France, United Kingdom, Germany
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, United States, Canada, Poland